ADAPY — Adaptimmune Therapeutics Share News
0.000.00%
Last trade - 00:00- $10.60m
- $10.22m
- $178.03m
Adaptimmune Therapeutics PLC expected to post a loss of 7 cents a share - Earnings Preview
Adaptimmune Therapeutics PLC expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Intel, Guardant, Ventas
FDA approves Adaptimmune's gene therapy for cancer, shares fall
US FDA approves Adaptimmune's gene therapy for rare type of cancer (updated)
US FDA approves Adaptimmune's gene therapy for rare cancer
Brief: Adaptimmune Receives U.S. FDA Accelerated Approval Of Tecelra
Brief: Galapagos And Adaptimmune Sign Clinical Collaboration Agreement With An Option To Exclusively License Adaptimmune’s Uza-Cel In Head & Neck Cancer And Potential Future Solid Tumor Indications
Adaptimmune Therapeutics PLC reports results for the quarter ended in March - Earnings Summary
Brief: Adaptimmune Therapeutics Believes Existing Cash, Cash Equivalents And Marketable Securities Will Fund Co’S Current Operations Into Late 2025
Brief: Adaptimmune Therapeutics Secures Up To $125 Million Debt Financing With Hercules Capital
Adaptimmune Therapeutics PLC expected to post a loss of 10 cents a share - Earnings Preview
Adaptimmune falls as Roche terminates cancer therapy deal
Brief: Adaptimmune Unit Receives Termination Notice Of Strategic Collaboration, License Agreement With Genentech
Adaptimmune Therapeutics PLC reports results for the quarter ended in December - Earnings Summary
Brief: Adaptimmune Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq
Brief: Adaptimmune Therapeutics FDA Accepted For Priority Review BLA For T-Cell Therapy For Advanced Synovial Sarcoma
Brief: Adaptimmune Completes Submission Of Rolling Biologics License Application (BLA) To U.S. FDA For Afami-Cel For The Treatment Of Advanced Synovial Sarcoma
Brief: Adaptimmune Reports Positive Data With LETE-CEL(1) From An Interim Analysis Of Pivotal IGNYTE-ESO Trial For People With Synovial Sarcoma Or MRCLS